ClinicalTrials.gg
Active, not recruitingNCT02117856Updated Jun 19, 2019

Complete Lower Dentures on 1 or 2 Implants

An interventional study of 1 implant placed surgically in the mandibular midline and 2 implants placed surgically in the mandibular canine sites in Tooth-loss, Edentulous Mouth and Complete Denture, sponsored by University of British Columbia. Active, not recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-19.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a randomized clinical trial to compare patient satisfaction and prosthetic outcomes with lower dentures retained by one or two implants. The investigators long-term objective is to establish evidence of the cost-effectiveness of a single implant intervention for improving tolerance to complete dentures. The investigators MAIN AIM will be to investigate patient satisfaction between and within groups with mandibular dentures retained by one or two implants over five years, and SECONDARILY to investigate the survival of implants, and the frequency of events to maintain the dentures and prosthetic attachments as clinically serviceable. Furthermore, multivariate analysis can assess the prediction of patient satisfaction with implant dentures based on various possible factors including age, health, demography and socioeconomic status, number of implants, and maintenance needs. Patient satisfaction will be measured by means of Visual Analogue Scales (VAS) including a measure of overall satisfaction and various specific aspects of satisfaction such as appearance, stability and comfort of the dentures.

The CENTRAL HYPOTHESIS is that mandibular complete dentures retained by single implants are at least as satisfying to patients over a five years period as those retained by two implants for the same period.

The SECONDARY HYPOTHESES are that:

i) there is no difference over five years between groups in the survival of original implants, or in the number of events for maintenance of the dentures or implant attachments; and ii) using each treatment group as it's own control, there is no change in patient satisfaction with lower dentures retained by either one or two implants during the five year loading period.

02

Conditions studied

  • Tooth-loss
  • Edentulous Mouth
  • Complete Denture
  • Complete Lower Denture

Keywords

  • Implant-Supported Denture
  • Single-Implant Denture
  • Patient Satisfaction
  • Edentulous Mandible
  • Dental Implants
  • Standard of Care
  • Randomized Clinical Trial
03

In context

Mouth, Edentulous

124 studies on the registry are indexed under Mouth, Edentulous; 17 are open to participants now.

This study's enrollment of 86 is above the median of 36 across 93 interventional studies indexed under Mouth, Edentulous.

Browse Mouth, Edentulous studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • functional in English or accompanied by a responsible adult who can provide translation services
  • able to consent to, and participate in, the treatment provided
  • available for the duration of the study
  • edentulous and with at least six month's experience with conventional complete dentures
  • currently wearing conventional complete dentures that are esthetically satisfactory to the patient and technically acceptable in the judgment of the study prosthodontist(s)
  • medically/psychologically suitable for implant surgery in the judgment of the study dentists

Exclusion criteria

Exclusion Criteria:

  • insufficient alveolar bone height for implant(s) (\< 10 mm)
  • history of head and neck radiation
  • systemic or neurological disease, including: (ASA) Class 3 with recently diagnosed severe systemic disease, e.g. recent (within 6 months) myocardial infarction or stroke; risks associated with bacteraemia, e.g. immune compromise, , in-dwelling catheters, stents, prosthetic heart valves, etc.; Type 1 diabetes, pituitary and adrenal insufficiency, and untreated hypothyroidism; chronic granulomatous disease, e.g. tuberculosis and sarcoidosis; bone disease, e.g. histiocytosis X, Paget's disease, fibrous dysplasia; history of congenital or acquired uncontrolled bleeding, e.g. coumadin
  • previous oral implant treatment
  • need for additional pre-prosthetic surgery
  • need for new complete dentures
  • medically/psychologically unsuitable for surgery in the opinion of the study dentists
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Active comparator
    1 implant

    Participants receive the following: 1 implant placed surgically in the mandibular midline; Soft reline of the existing complete lower denture; 2.25mm ball patrix placed on 1 healed implant; and Reline with 1 retentive matrix in the lower denture.

    Procedure: 1 implant placed surgically in the mandibular midline · Procedure: Soft reline (Coe Comfort) of the existing complete lower denture · Device: 2.25mm ball patrix placed on 1 healed implant · Procedure: Reline (Ivoclar acrylic-resin) with 1 retentive matrix in the lower denture

  • Active comparator
    2 implants

    Participants receive the following: 2 implants placed surgically in the mandibular canine sites; Soft reline of the existing complete lower denture; 2.25mm ball patrices placed on 2 healed implants; and Reline with 2 retentive matrices in the lower denture.

    Procedure: 2 implants placed surgically in the mandibular canine sites · Procedure: Soft reline (Coe Comfort) of the existing complete lower denture · Device: 2.25mm ball patrices placed on 2 healed implants · Procedure: Reline (Ivoclar acrylic-resin) with 2 retentive matrices in the lower denture

Interventions

  • Procedure1 implant placed surgically in the mandibular midline

    Participants receive an implant in the mandibular midline using a surgical flap procedure with local anaesthesia.

    Also known as: Implant is Solid Screw, SLA surface, Straumann Canada

  • Procedure2 implants placed surgically in the mandibular canine sites

    Participants receive implants bilaterally in the site of the mandibular canines using a surgical flap procedure with local anaesthesia.

    Also known as: Implants are Solid Screw, SLA surface, Straumann Canada

  • ProcedureSoft reline (Coe Comfort) of the existing complete lower denture

    Participants receive a soft reline of the existing complete lower denture approximately 10 days after placement of the implant(s).

    Also known as: Soft reline is Coe Comfort, GC Corporation

  • Device2.25mm ball patrix placed on 1 healed implant

    A 2.25mm ball patrix is screwed onto the 1 implant approximately six weeks after placement of the implant.

    Also known as: Patrix is Spherical Stud Retentive Anchor, Straumann Canada

  • Device2.25mm ball patrices placed on 2 healed implants

    2.25mm ball patrices are screwed onto the 2 implants approximately six weeks after placement of the implants.

    Also known as: Patrix is Spherical Stud Retentive Anchor, Straumann Canada

  • ProcedureReline (Ivoclar acrylic-resin) with 1 retentive matrix in the lower denture

    Participants have their complete lower denture relined with a laboratory-processed acrylic resin to incorporate 1 retentive matrix in the denture-base to retain on the implant.

    Also known as: Reline is Ivoclar acrylic-resin, Ivoclar Vivaent Inc, Canada, Matrix is Straumann Gold Matrix, Straumann Canada

  • ProcedureReline (Ivoclar acrylic-resin) with 2 retentive matrices in the lower denture

    Participants have their complete lower denture relined with a laboratory-processed acrylic resin to incorporate 2 retentive matrices in the denture-base to retain on the implants

    Also known as: Reline is Ivoclar acrylic-resin, Ivoclar Vivaent Inc, Canada, Matrix is Straumann Gold Matrix, Straumann Canada

06

What researchers measure

Primary outcomes

  1. Self-assessed VAS satisfaction with the mandibular denture

    Self-assessed satisfaction is measured on a 10 cm uninterrupted visual analogue scale (VAS) representing a continuum of feelings, with "unsatisfied" at one end and "satisfied" at the other. Each participant makes a global assessment of their satisfaction by marking an X on the line at a point corresponding to their response to the question: "How would you evaluate your 'overall satisfaction' with your lower denture?". A research assistant translates the mark into a number from 0 to 100 by superimposing a template with numbered intervals from 0 to 100 mm.

    Time frame: Annually during 10 years after attaching the mandibular implant denture

Secondary outcomes

  1. Change in self-assessed VAS satisfaction with the mandibular denture

    Self-assessed satisfaction is measured on a 10 cm uninterrupted visual analogue scale (VAS) representing a continuum of feelings, with "unsatisfied" at one end and "satisfied" at the other. Each participant makes a global assessment of their satisfaction by marking an X on the line at a point corresponding to their response to the question: "How would you evaluate your 'overall satisfaction' with your lower denture?". A research assistant translates the mark into a number from 0 to 100 by superimposing a template with numbered intervals from 0 to 100 mm.

    Time frame: From baseline (before implants) to each annual followup for 10 years after attaching the mandibular implant denture

  2. Cumulative Implant Survival

    Cumulative implant survival was judged by the time to the presence of clinical mobility, pain or suppuration associated with the original mandibular implants.

    Time frame: During the 10 years after attaching the mandibular implant denture

  3. The frequency of prosthetic maintenance events for the mandibular implant overdenture

    The frequency of prosthetic maintenance treatment events for the mandibular denture including adjustment, reattachment, or replacement of implant attachment components, and denture base fractures, relining or rebasing, and denture replacement with a new lower denture.

    Time frame: During 10 years after attaching the mandibular implant denture

  4. Time to provide the initial surgical and prosthetic treatment for the mandibular implant overdenture intervention

    This is the total professional chair-time recorded to provide the initial surgical and prosthetic treatment for the mandibular implant overdenture intervention.

    Time frame: From baseline (before implants) until attachment of the mandibular implant denture, 6 weeks after implant placement

  5. Costs to provide the initial surgical and prosthetic treatment for the mandibular implant overdenture intervention

    This is the total cost of components and professional and dental laboratory fees to provide the initial surgical and prosthetic treatment for the mandibular implant overdenture intervention.

    Time frame: From baseline (before implants) until attachment of the mandibular implant denture, 6 weeks after implant placement

  6. Time to provide prosthetic maintenance treatment for the mandibular implant overdenture

    This is the total professional chair-time recorded to provide prosthetic maintenance treatment for the maxillary denture and the mandibular implant overdenture including contour adjustments, and adjustment, reattachment, or replacement of implant attachment components, and denture repairs, relining or rebasing.

    Time frame: During 1 year after attachment of the mandibular implant denture

  7. Costs to provide prosthetic maintenance treatment for the mandibular implant overdenture

    This is the total cost of components and professional and dental laboratory fees to provide prosthetic maintenance treatment for the maxillary denture and the mandibular implant overdenture including contour adjustments, and adjustment, reattachment, or replacement of implant attachment components, and denture repairs, relining or rebasing.

    Time frame: During 1 year after attachment of the mandibular implant denture

07

Study locations

1 site
  • Department of Oral Health Sciences, University of British Columbia
    Vancouver, British Columbia V6T 1Z3, Canada
08

References and documents

Publications

  • Walton JN, MacEntee MI. Choosing or refusing oral implants: a prospective study of edentulous volunteers for a clinical trial. Int J Prosthodont. 2005 Nov-Dec;18(6):483-8. PubMed 16335167 ↗
  • Walton JN, MacEntee MI. Screening and enrolling subjects in a randomized clinical trial involving implant dentures. Int J Prosthodont. 2008 May-Jun;21(3):210-4. PubMed 18548957 ↗
  • Walton JN, Glick N, Macentee MI. A randomized clinical trial comparing patient satisfaction and prosthetic outcomes with mandibular overdentures retained by one or two implants. Int J Prosthodont. 2009 Jul-Aug;22(4):331-9. PubMed 19639067 ↗
  • Gonda T, Maeda Y, Walton JN, MacEntee MI. Fracture incidence in mandibular overdentures retained by one or two implants. J Prosthet Dent. 2010 Mar;103(3):178-81. doi: 10.1016/S0022-3913(10)60026-1. PubMed 20188240 ↗
  • Bryant SR, Walton JN, MacEntee MI. A 5-year randomized trial to compare 1 or 2 implants for implant overdentures. J Dent Res. 2015 Jan;94(1):36-43. doi: 10.1177/0022034514554224. Epub 2014 Oct 27. PubMed 25348544 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2002, a primary completion of Jun 2027 and a completion of Jun 2027. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2014
First posted
Apr 21, 2014
Start
Nov 2002
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Jun 19, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02117856
Collaborators
ITI International Team for Implantology, Switzerland, Canadian Institutes of Health Research (CIHR), Straumann Canada Ltd.
Responsible party
Ross Bryant (Assistant Professor, University of British Columbia) — Principal investigator
First posted
Apr 21, 2014
Start date
Nov 2002
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jun 19, 2019

Study contacts

Stephen R. Bryant, DDS, PhD
principal investigator · University of British Columbia
Michael I. MacEntee, LDS, PhD
study director · University of British Columbia
Joanne N. Walton, DDS
study director · University of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion